+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Home Healthcare Market Size, Share & Industry Trends Analysis Report By Type (Services and Product), By Indication, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 320 Pages
  • December 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5723924
The Global Home Healthcare Market size is expected to reach $405.6 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Supportive care is given in the home and is known as home care or home health care. While receiving assistance to recuperate from sickness, accident, or handicap, home care enables a person to stay in the comfort of their own home. The typical healthcare setting, including a hospital, rehabilitation center, skilled nursing facility, or long-term care environment, may not always be the only place where healthcare and support services are offered.



As their health care and daily life requirements are taken care of, people may stay in the comfort of their homes, close to their loved ones, when they get care at home. Patients who get home healthcare services have a team of healthcare professionals working with them to manage their needs and those of their families. Chronic illnesses, including diabetes, hypertension, HIV/AIDS, heart failure, cancer, and chronic obstructive pulmonary disease, are all covered by home care services (COPD). People with physical or cognitive impairments may get home care to assist them in carrying out everyday tasks.

Patients who are receiving hospice care may also get care at home. Patients with a prognosis of six months or less that have been diagnosed with a terminal disease (a condition that cannot be cured) are eligible for hospice home care. People with a terminal disease are able to stay in the comfort of their own homes, accompanied by familiar people and objects, owing to hospice home care.

Depending on their physical state and particular ailment or injury, people who get home care have a range of demands. Patients may want assistance or reminders to take their prescriptions. Patients often need help walking, moving from a bed to a chair or wheelchair, or entering and exiting the shower. Many patients have mobility aids that help them go about their homes, such as wheelchairs, canes, walkers, and prosthetic devices.

COVID-19 Impact Analysis

The COVID-19 pandemic's impact on the world market for home healthcare has been conflicting. The sales of several home healthcare equipment, including blood pressure monitors, pulse oximeters, blood glucose monitors, and temperature monitors, have benefited from COVID-19. Due to increased knowledge of the possible dangers in case of infection, people all around the globe are buying more of these products. The home medical device sector has seen increased sales as a consequence of the pandemic. Providers of home healthcare services are now concentrating on adjusting to the pandemic by being responsive to changing client expectations.

Market Growth Factors

Growing elderly population

WHO estimates that by 2030, 1 in 6 individuals worldwide would be 60 years of age or older. From 1 billion in 2020, there will be 1.4 billion persons over the age of 60 by this time. By 2050, there will be twice as many people worldwide who are 60 years of age or older. 2 billion. The number of persons 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million. Due to the rising number of elderly people and the high risk of health problems in this age group, demand for improved healthcare facilities and the convenience of avoiding hospitals develop. This has led to home healthcare becoming more and more popular.

Increasing prevalence of chronic illnesses

WHO estimates that there were 108 million cases of diabetes in 1980 and 422 million cases in 2014. Compared to high-income countries, prevalence has been increasing more quickly in low- and middle-income nations. Diabetes is a significant contributor to renal disease, heart attacks, blindness, strokes, and lower limb amputation. Due to the increased frequency of chronic illnesses, there is now a healthcare crisis with high expenditures, poor access to treatment, and subpar care quality. As a consequence, there is a growing need for home healthcare facilities all over the world.

Market Restraining Factors

Limited Insurance Protection

In many industrialized countries, home healthcare services are covered by insurance; nevertheless, Medicare-certified home healthcare firms are the only ones who can make use of this insurance. Equipment needed for rehabilitation, telemetry, or multi-parameter monitoring is not covered by insurance. In these countries, insurance coverage for this equipment varies. In many nations, insurance companies only pay for in-home healthcare services for the elderly and those with chronic diseases if they are in post-hospitalization therapy.

Type Outlook

On the basis of type, the home healthcare market is divided into services and product. In 2021, the product segment acquired a remarkable revenue share in the home healthcare market. This is because of the wide availability of home healthcare and diagnosis products such as diabetes home diagnosis test kit. The demand for home healthcare products is further growing due to the rising prevalence of obesity, diabetes, eye disorders and other such issues.



Product Outlook

Based on product type, the home healthcare market is classified into therapeutics; testing, screening, monitoring; and mobility care. The therapeutics products category held the largest revenue share in the home healthcare market in 2021. The prevalence of illnesses requiring regular use of therapeutic equipment, such as insulin delivery systems, home dialysis systems, and intravenous pumps, is the source of this expansion.

Services Outlook

Based on service type, the home healthcare market is classified into skilled nursing, rehabilitation therapy, unskilled care, hospice & palliative care, respiratory therapy, infusion treatment, and pregnancy care. In 2021, the skilled nursing sector had the major revenue share 2021. When someone has a severe or chronic ailment and needs support to manage it, particularly in the wake of the pandemic, skilled nursing at home is one such dependable and affordable alternative they might choose. Seniors use these services the most often, mostly because they have trouble getting about the city on their own.

Indication Outlook

Based on Indication, the home healthcare market is divided into diabetes, cancer, wound care, pregnancy, respiratory disease, movement disorders, cardiovascular diseases & hypertension, and other indications. The cancer & other indications sector had the highest revenue share in 2021. All across the globe, cancer seems to be quite common. Home healthcare may be very beneficial for a cancer patient and ease the stress on the family.

Regional Outlook

Based on geography, the home healthcare market is classified into North America, Europe, Asia Pacific, and LAMEA. With the largest revenue share, the North American region dominated the home healthcare market in 2021. The market for home healthcare was dominated by North America. Due to its better healthcare infrastructure and increased prevalence of chronic diseases, North America holds a sizable portion of the worldwide market. Some of the important variables are the region's sizable aging population, advanced healthcare infrastructure, and comparatively higher levels of disposable income.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.

Strategies Deployed in Home Healthcare Market

  • 2022-Aug: LHC Group, Inc. took over Three Rivers Home Health, a Georgia-based home health provider. Through this acquisition, LHC Group's service area would be broadened. Moreover, this acquisition complements LHC Group's co-location plan to supply various in-home healthcare services in specific markets, along with its techniques of controlling and operating under a family of well-known regional brands.
  • 2022-Apr: Amedisys, Inc. acquired AssistedCare Home Health, Inc., a leading partner in providing home and community-based healthcare, and RH Homecare Services, LLC, a company engaged in providing a spectrum of services primarily to all individuals who need care in the home setting. Under this acquisition, Amedisys would be able to broaden its reach in healthcare communities and deliver more extensive care by complementing its Amedisys Hospice presence in North Carolina.
  • 2022-Mar: LHC Group, Inc. came into collaboration with Optum, a diversified health services company. Under this collaboration, LHC Group would further strengthen its capability to promote value-based care. Furthermore, both companies would work together with the focus on caring for the most vulnerable in society which would help LHC Group to effectively and efficiently provide better and growing value-based care in the home.
  • 2021-Jul: LHC Group, Inc. partnered with SCP Health, a national clinical leader in acute unscheduled care. Under this partnership, LHC Group, Inc., would be able to supply a wide offering of clinicians covering all verticals of home health care consisting of hospital-at-home programs and skilled nursing facility (SNF)-at home.
  • 2021-Jun: Amedisys, Inc. took over Contessa Health, a company engaged in delivering hospital-at-home and skilled nursing-at-home services. Under this acquisition, Amedisys would broaden its ability to reflect rising market demands and growing patient preference for higher-acuity in-home settings.
  • 2020-Aug: Amedisys, Inc. signed an agreement with BrightStar Care, a comprehensive healthcare service staffing agency that offers medical and non-medical homecare to private clients within their homes. This agreement broadens Amedisys’ care network to 39 states with 1, 211 partner agencies.
  • 2019-Mar: ResMed, Inc. took over HB Healthcare, a provider of home medical equipment. Through this acquisition, ResMed plans to reach more patients through HBH and its broad network of distributor partners.
  • 2019-Feb: Fresenius Medical Care took over NxStage Medical, Inc, a company that develops, produces, and markets an innovative product suite of medical devices for use in critical care and home dialysis. Through this acquisition, Fresenius Medical Care would enhance its supply chain, manufacturing, and marketing ability over the Care Coordination, services, and dialysis products.
  • 2018-Jul: ResMed, Inc., acquired HEALTHCAREfirst, a provider of software solutions and services for home health and hospice agencies. Through this acquisition, ResMed would aim to support homecare and HME providers manage their business and enhance the lives of their patients as an aging population moves to homecare and different lower-cost settings.

Scope of the Study

By Type

  • Services
    • Skilled Nursing
    • Rehabilitation Therapy
    • Hospice & Palliative Care
    • Unskilled Care
    • Respiratory Therapy
    • Infusion Therapy
    • Pregnancy Care
  • Product
    • Therapeutic Products
    • Testing, Screening, & Monitoring Products
    • Mobility Care Products

By Indication

  • Cancer & Other Indications
  • Respiratory Diseases
  • Wound Care
  • Pregnancy
  • Movement Disorders
  • Hearing Disorders
  • Cardiovascular Diseases & Hypertension
  • Diabetes

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Amedisys, Inc.
  • LHC Group, Inc.
  • ResMed, Inc.
  • Omron Corporation
  • Abbott Laboratories
  • Invacare Corporation
  • Linde PLC
  • A&D HOLON Holdings Company, Limited
  • Fresenius SE & Co. KGaA
  • F.Hoffmann-La Roche Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Home Healthcare Market, by Type
1.4.2 Global Home Healthcare Market, by Indication
1.4.3 Global Home Healthcare Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Home Healthcare Market

Chapter 4. Global Home Healthcare Market by Type
4.1 Global Services Market by Region
4.2 Global Home Healthcare Market by Services Type
4.2.1 Global Skilled Nursing Market by Region
4.2.2 Global Rehabilitation Therapy Market by Region
4.2.3 Global Hospice & Palliative Care Market by Region
4.2.4 Global Unskilled Care Market by Region
4.2.5 Global Respiratory Therapy Market by Region
4.2.6 Global Infusion Therapy Market by Region
4.2.7 Global Pregnancy Care Market by Region
4.3 Global Product Market by Region
4.4 Global Home Healthcare Market by Product Type
4.4.1 Global Therapeutic Products Market by Region
4.4.2 Global Testing, Screening, & Monitoring Products Market by Region
4.4.3 Global Mobility Care Products Market by Region

Chapter 5. Global Home Healthcare Market by Indication
5.1 Global Cancer & Other Indications Market by Region
5.2 Global Respiratory Diseases Market by Region
5.3 Global Wound Care Market by Region
5.4 Global Pregnancy Market by Region
5.5 Global Movement Disorders Market by Region
5.6 Global Hearing Disorders Market by Region
5.7 Global Cardiovascular Diseases & Hypertension Market by Region
5.8 Global Diabetes Market by Region

Chapter 6. Global Home Healthcare Market by Region
6.1 North America Home Healthcare Market
6.1.1 North America Home Healthcare Market by Type
6.1.1.1 North America Services Market by Country
6.1.1.2 North America Home Healthcare Market by Services Type
6.1.1.2.1 North America Skilled Nursing Market by Country
6.1.1.2.2 North America Rehabilitation Therapy Market by Country
6.1.1.2.3 North America Hospice & Palliative Care Market by Country
6.1.1.2.4 North America Unskilled Care Market by Country
6.1.1.2.5 North America Respiratory Therapy Market by Country
6.1.1.2.6 North America Infusion Therapy Market by Country
6.1.1.2.7 North America Pregnancy Care Market by Country
6.1.1.3 North America Product Market by Country
6.1.1.4 North America Home Healthcare Market by Product Type
6.1.1.4.1 North America Therapeutic Products Market by Country
6.1.1.4.2 North America Testing, Screening, & Monitoring Products Market by Country
6.1.1.4.3 North America Mobility Care Products Market by Country
6.1.2 North America Home Healthcare Market by Indication
6.1.2.1 North America Cancer & Other Indications Market by Country
6.1.2.2 North America Respiratory Diseases Market by Country
6.1.2.3 North America Wound Care Market by Country
6.1.2.4 North America Pregnancy Market by Country
6.1.2.5 North America Movement Disorders Market by Country
6.1.2.6 North America Hearing Disorders Market by Country
6.1.2.7 North America Cardiovascular Diseases & Hypertension Market by Country
6.1.2.8 North America Diabetes Market by Country
6.1.3 North America Home Healthcare Market by Country
6.1.3.1 US Home Healthcare Market
6.1.3.1.1 US Home Healthcare Market by Type
6.1.3.1.1.1 US Home Healthcare Market by Services Type
6.1.3.1.1.2 US Home Healthcare Market by Product Type
6.1.3.1.2 US Home Healthcare Market by Indication
6.1.3.2 Canada Home Healthcare Market
6.1.3.2.1 Canada Home Healthcare Market by Type
6.1.3.2.1.1 Canada Home Healthcare Market by Services Type
6.1.3.2.1.2 Canada Home Healthcare Market by Product Type
6.1.3.2.2 Canada Home Healthcare Market by Indication
6.1.3.3 Mexico Home Healthcare Market
6.1.3.3.1 Mexico Home Healthcare Market by Type
6.1.3.3.1.1 Mexico Home Healthcare Market by Services Type
6.1.3.3.1.2 Mexico Home Healthcare Market by Product Type
6.1.3.3.2 Mexico Home Healthcare Market by Indication
6.1.3.4 Rest of North America Home Healthcare Market
6.1.3.4.1 Rest of North America Home Healthcare Market by Type
6.1.3.4.1.1 Rest of North America Home Healthcare Market by Services Type
6.1.3.4.1.2 Rest of North America Home Healthcare Market by Product Type
6.1.3.4.2 Rest of North America Home Healthcare Market by Indication
6.2 Europe Home Healthcare Market
6.2.1 Europe Home Healthcare Market by Type
6.2.1.1 Europe Services Market by Country
6.2.1.2 Europe Home Healthcare Market by Services Type
6.2.1.2.1 Europe Skilled Nursing Market by Country
6.2.1.2.2 Europe Rehabilitation Therapy Market by Country
6.2.1.2.3 Europe Hospice & Palliative Care Market by Country
6.2.1.2.4 Europe Unskilled Care Market by Country
6.2.1.2.5 Europe Respiratory Therapy Market by Country
6.2.1.2.6 Europe Infusion Therapy Market by Country
6.2.1.2.7 Europe Pregnancy Care Market by Country
6.2.1.3 Europe Product Market by Country
6.2.1.4 Europe Home Healthcare Market by Product Type
6.2.1.4.1 Europe Therapeutic Products Market by Country
6.2.1.4.2 Europe Testing, Screening, & Monitoring Products Market by Country
6.2.1.4.3 Europe Mobility Care Products Market by Country
6.2.2 Europe Home Healthcare Market by Indication
6.2.2.1 Europe Cancer & Other Indications Market by Country
6.2.2.2 Europe Respiratory Diseases Market by Country
6.2.2.3 Europe Wound Care Market by Country
6.2.2.4 Europe Pregnancy Market by Country
6.2.2.5 Europe Movement Disorders Market by Country
6.2.2.6 Europe Hearing Disorders Market by Country
6.2.2.7 Europe Cardiovascular Diseases & Hypertension Market by Country
6.2.2.8 Europe Diabetes Market by Country
6.2.3 Europe Home Healthcare Market by Country
6.2.3.1 Germany Home Healthcare Market
6.2.3.1.1 Germany Home Healthcare Market by Type
6.2.3.1.1.1 Germany Home Healthcare Market by Services Type
6.2.3.1.1.2 Germany Home Healthcare Market by Product Type
6.2.3.1.2 Germany Home Healthcare Market by Indication
6.2.3.2 UK Home Healthcare Market
6.2.3.2.1 UK Home Healthcare Market by Type
6.2.3.2.1.1 UK Home Healthcare Market by Services Type
6.2.3.2.1.2 UK Home Healthcare Market by Product Type
6.2.3.2.2 UK Home Healthcare Market by Indication
6.2.3.3 France Home Healthcare Market
6.2.3.3.1 France Home Healthcare Market by Type
6.2.3.3.1.1 France Home Healthcare Market by Services Type
6.2.3.3.1.2 France Home Healthcare Market by Product Type
6.2.3.3.2 France Home Healthcare Market by Indication
6.2.3.4 Russia Home Healthcare Market
6.2.3.4.1 Russia Home Healthcare Market by Type
6.2.3.4.1.1 Russia Home Healthcare Market by Services Type
6.2.3.4.1.2 Russia Home Healthcare Market by Product Type
6.2.3.4.2 Russia Home Healthcare Market by Indication
6.2.3.5 Spain Home Healthcare Market
6.2.3.5.1 Spain Home Healthcare Market by Type
6.2.3.5.1.1 Spain Home Healthcare Market by Services Type
6.2.3.5.1.2 Spain Home Healthcare Market by Product Type
6.2.3.5.2 Spain Home Healthcare Market by Indication
6.2.3.6 Italy Home Healthcare Market
6.2.3.6.1 Italy Home Healthcare Market by Type
6.2.3.6.1.1 Italy Home Healthcare Market by Services Type
6.2.3.6.1.2 Italy Home Healthcare Market by Product Type
6.2.3.6.2 Italy Home Healthcare Market by Indication
6.2.3.7 Rest of Europe Home Healthcare Market
6.2.3.7.1 Rest of Europe Home Healthcare Market by Type
6.2.3.7.1.1 Rest of Europe Home Healthcare Market by Services Type
6.2.3.7.1.2 Rest of Europe Home Healthcare Market by Product Type
6.2.3.7.2 Rest of Europe Home Healthcare Market by Indication
6.3 Asia Pacific Home Healthcare Market
6.3.1 Asia Pacific Home Healthcare Market by Type
6.3.1.1 Asia Pacific Services Market by Country
6.3.1.2 Asia Pacific Home Healthcare Market by Services Type
6.3.1.2.1 Asia Pacific Skilled Nursing Market by Country
6.3.1.2.2 Asia Pacific Rehabilitation Therapy Market by Country
6.3.1.2.3 Asia Pacific Hospice & Palliative Care Market by Country
6.3.1.2.4 Asia Pacific Unskilled Care Market by Country
6.3.1.2.5 Asia Pacific Respiratory Therapy Market by Country
6.3.1.2.6 Asia Pacific Infusion Therapy Market by Country
6.3.1.2.7 Asia Pacific Pregnancy Care Market by Country
6.3.1.3 Asia Pacific Product Market by Country
6.3.1.4 Asia Pacific Home Healthcare Market by Product Type
6.3.1.4.1 Asia Pacific Therapeutic Products Market by Country
6.3.1.4.2 Asia Pacific Testing, Screening, & Monitoring Products Market by Country
6.3.1.4.3 Asia Pacific Mobility Care Products Market by Country
6.3.2 Asia Pacific Home Healthcare Market by Indication
6.3.2.1 Asia Pacific Cancer & Other Indications Market by Country
6.3.2.2 Asia Pacific Respiratory Diseases Market by Country
6.3.2.3 Asia Pacific Wound Care Market by Country
6.3.2.4 Asia Pacific Pregnancy Market by Country
6.3.2.5 Asia Pacific Movement Disorders Market by Country
6.3.2.6 Asia Pacific Hearing Disorders Market by Country
6.3.2.7 Asia Pacific Cardiovascular Diseases & Hypertension Market by Country
6.3.2.8 Asia Pacific Diabetes Market by Country
6.3.3 Asia Pacific Home Healthcare Market by Country
6.3.3.1 China Home Healthcare Market
6.3.3.1.1 China Home Healthcare Market by Type
6.3.3.1.1.1 China Home Healthcare Market by Services Type
6.3.3.1.1.2 China Home Healthcare Market by Product Type
6.3.3.1.2 China Home Healthcare Market by Indication
6.3.3.2 Japan Home Healthcare Market
6.3.3.2.1 Japan Home Healthcare Market by Type
6.3.3.2.1.1 Japan Home Healthcare Market by Services Type
6.3.3.2.1.2 Japan Home Healthcare Market by Product Type
6.3.3.2.2 Japan Home Healthcare Market by Indication
6.3.3.3 India Home Healthcare Market
6.3.3.3.1 India Home Healthcare Market by Type
6.3.3.3.1.1 India Home Healthcare Market by Services Type
6.3.3.3.1.2 India Home Healthcare Market by Product Type
6.3.3.3.2 India Home Healthcare Market by Indication
6.3.3.4 South Korea Home Healthcare Market
6.3.3.4.1 South Korea Home Healthcare Market by Type
6.3.3.4.1.1 South Korea Home Healthcare Market by Services Type
6.3.3.4.1.2 South Korea Home Healthcare Market by Product Type
6.3.3.4.2 South Korea Home Healthcare Market by Indication
6.3.3.5 Singapore Home Healthcare Market
6.3.3.5.1 Singapore Home Healthcare Market by Type
6.3.3.5.1.1 Singapore Home Healthcare Market by Services Type
6.3.3.5.1.2 Singapore Home Healthcare Market by Product Type
6.3.3.5.2 Singapore Home Healthcare Market by Indication
6.3.3.6 Malaysia Home Healthcare Market
6.3.3.6.1 Malaysia Home Healthcare Market by Type
6.3.3.6.1.1 Malaysia Home Healthcare Market by Services Type
6.3.3.6.1.2 Malaysia Home Healthcare Market by Product Type
6.3.3.6.2 Malaysia Home Healthcare Market by Indication
6.3.3.7 Rest of Asia Pacific Home Healthcare Market
6.3.3.7.1 Rest of Asia Pacific Home Healthcare Market by Type
6.3.3.7.1.1 Rest of Asia Pacific Home Healthcare Market by Services Type
6.3.3.7.1.2 Rest of Asia Pacific Home Healthcare Market by Product Type
6.3.3.7.2 Rest of Asia Pacific Home Healthcare Market by Indication
6.4 LAMEA Home Healthcare Market
6.4.1 LAMEA Home Healthcare Market by Type
6.4.1.1 LAMEA Services Market by Country
6.4.1.2 LAMEA Home Healthcare Market by Services Type
6.4.1.2.1 LAMEA Skilled Nursing Market by Country
6.4.1.2.2 LAMEA Rehabilitation Therapy Market by Country
6.4.1.2.3 LAMEA Hospice & Palliative Care Market by Country
6.4.1.2.4 LAMEA Unskilled Care Market by Country
6.4.1.2.5 LAMEA Respiratory Therapy Market by Country
6.4.1.2.6 LAMEA Infusion Therapy Market by Country
6.4.1.2.7 LAMEA Pregnancy Care Market by Country
6.4.1.3 LAMEA Product Market by Country
6.4.1.4 LAMEA Home Healthcare Market by Product Type
6.4.1.4.1 LAMEA Therapeutic Products Market by Country
6.4.1.4.2 LAMEA Testing, Screening, & Monitoring Products Market by Country
6.4.1.4.3 LAMEA Mobility Care Products Market by Country
6.4.2 LAMEA Home Healthcare Market by Indication
6.4.2.1 LAMEA Cancer & Other Indications Market by Country
6.4.2.2 LAMEA Respiratory Diseases Market by Country
6.4.2.3 LAMEA Wound Care Market by Country
6.4.2.4 LAMEA Pregnancy Market by Country
6.4.2.5 LAMEA Movement Disorders Market by Country
6.4.2.6 LAMEA Hearing Disorders Market by Country
6.4.2.7 LAMEA Cardiovascular Diseases & Hypertension Market by Country
6.4.2.8 LAMEA Diabetes Market by Country
6.4.3 LAMEA Home Healthcare Market by Country
6.4.3.1 Brazil Home Healthcare Market
6.4.3.1.1 Brazil Home Healthcare Market by Type
6.4.3.1.1.1 Brazil Home Healthcare Market by Services Type
6.4.3.1.1.2 Brazil Home Healthcare Market by Product Type
6.4.3.1.2 Brazil Home Healthcare Market by Indication
6.4.3.2 Argentina Home Healthcare Market
6.4.3.2.1 Argentina Home Healthcare Market by Type
6.4.3.2.1.1 Argentina Home Healthcare Market by Services Type
6.4.3.2.1.2 Argentina Home Healthcare Market by Product Type
6.4.3.2.2 Argentina Home Healthcare Market by Indication
6.4.3.3 UAE Home Healthcare Market
6.4.3.3.1 UAE Home Healthcare Market by Type
6.4.3.3.1.1 UAE Home Healthcare Market by Services Type
6.4.3.3.1.2 UAE Home Healthcare Market by Product Type
6.4.3.3.2 UAE Home Healthcare Market by Indication
6.4.3.4 Saudi Arabia Home Healthcare Market
6.4.3.4.1 Saudi Arabia Home Healthcare Market by Type
6.4.3.4.1.1 Saudi Arabia Home Healthcare Market by Services Type
6.4.3.4.1.2 Saudi Arabia Home Healthcare Market by Product Type
6.4.3.4.2 Saudi Arabia Home Healthcare Market by Indication
6.4.3.5 South Africa Home Healthcare Market
6.4.3.5.1 South Africa Home Healthcare Market by Type
6.4.3.5.1.1 South Africa Home Healthcare Market by Services Type
6.4.3.5.1.2 South Africa Home Healthcare Market by Product Type
6.4.3.5.2 South Africa Home Healthcare Market by Indication
6.4.3.6 Nigeria Home Healthcare Market
6.4.3.6.1 Nigeria Home Healthcare Market by Type
6.4.3.6.1.1 Nigeria Home Healthcare Market by Services Type
6.4.3.6.1.2 Nigeria Home Healthcare Market by Product Type
6.4.3.6.2 Nigeria Home Healthcare Market by Indication
6.4.3.7 Rest of LAMEA Home Healthcare Market
6.4.3.7.1 Rest of LAMEA Home Healthcare Market by Type
6.4.3.7.1.1 Rest of LAMEA Home Healthcare Market by Services Type
6.4.3.7.1.2 Rest of LAMEA Home Healthcare Market by Product Type
6.4.3.7.2 Rest of LAMEA Home Healthcare Market by Indication

Chapter 7. Company Profiles
7.1 Amedisys, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Acquisition and Mergers:
7.2 LHC Group, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Partnerships, Collaborations, and Agreements:
7.2.4.2 Acquisition and Mergers:
7.3 ResMed, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Omron Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Invacare Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Linde PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 A&D HOLON Holdings Company, Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.9 Fresenius SE & Co. KGaA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. F. Hoffmann-La Roche Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense

Companies Mentioned

  • Amedisys, Inc.
  • LHC Group, Inc.
  • ResMed, Inc.
  • Omron Corporation
  • Abbott Laboratories
  • Invacare Corporation
  • Linde PLC
  • A&D HOLON Holdings Company, Limited
  • Fresenius SE & Co. KGaA
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...